Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
22.43
+0.32 (1.42%)
Oct 1, 2025, 4:00 PM EDT - Market closed
Omada Health Stock Forecast
Stock Price Forecast
The 7 analysts that cover Omada Health stock have a consensus rating of "Strong Buy" and an average price target of $24.86, which forecasts a 10.86% increase in the stock price over the next year. The lowest target is $20 and the highest is $29.
Price Target: $24.86 (+10.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Omada Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|
| Strong Buy | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 |
| Hold | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Initiates $24 | Hold | Initiates | $24 | +7.02% | Sep 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $27 → $28 | Strong Buy | Maintains | $27 → $28 | +24.86% | Aug 8, 2025 |
| Barclays | Barclays | Buy Maintains $21 → $24 | Buy | Maintains | $21 → $24 | +7.02% | Aug 8, 2025 |
| Needham | Needham | Strong Buy Maintains $23 → $24 | Strong Buy | Maintains | $23 → $24 | +7.02% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $20 | Buy | Initiates | $20 | -10.81% | Jul 1, 2025 |
Financial Forecast
Revenue This Year
243.53M
from 169.80M
Increased by 43.42%
Revenue Next Year
292.25M
from 243.53M
Increased by 20.01%
EPS This Year
-0.37
from -6.10
EPS Next Year
-0.06
from -0.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 253.0M | 306.1M | |
| Avg | 243.5M | 292.3M | |
| Low | 231.3M | 274.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 49.0% | 25.7% | |
| Avg | 43.4% | 20.0% | |
| Low | 36.2% | 12.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.12 | 0.09 | |
| Avg | -0.37 | -0.06 | |
| Low | -0.66 | -0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.